Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Teva Pharmaceutical Gets Reprieve After Analyst Upgrade
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceutical Industries Limited (TEVA) Stock 10 Year History